# Biocon to build $100M fermentation API plant in Visakhapatnam, India

Biocon is investing $100 million in a new fermentation-based active pharmaceutical ingredient (API) production facility in Visakhapatnam, India. The facility is scheduled to be commissioned by the end of 2021.

- Type: New facility
- Announced: 2020-04-07
- Where: Visakhapatnam, India
- Value: $100.0M
- Starts operating: 2021
- Status: announced
- Capacity: 2 x 100-KL and 2 x 10-KL fermenters
- Products: fermentation-based active pharmaceutical ingredients, drug substances, intermediates
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Biocon](https://endata.com/companies/46388.md)

## Sources

- [dcatvci.org](https://www.dcatvci.org/supplier-news/biocon-investing-100-million-in-new-fermentation-based-api-mfg-facility/), 2020-04-07: "Biocon is investing $100 million in a new fermentation production facility for drug substances and intermediates in Visakhapatnam."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.